Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.
White KD, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard C, Carleton B, Chodosh J, Cibotti R, Davis R, Denny JC, Dodiuk-Gad RP, Ergen EN, Goldman JL, Holmes JH 4th, Hung SI, Lacouture ME, Lehloenya RJ, Mallal S, Manolio TA, Micheletti RG, Mitchell CM, Mockenhaupt M, Ostrov DA, Pavlos R, Pirmohamed M, Pope E, Redwood A, Rosenbach M, Rosenblum MD, Roujeau JC, Saavedra AP, Saeed HN, Struewing JP, Sueki H, Sukasem C, Sung C, Trubiano JA, Weintraub J, Wheatley LM, Williams KB, Worley B, Chung WH, Shear NH, Phillips EJ. White KD, et al. Among authors: abe r. J Allergy Clin Immunol Pract. 2018 Jan-Feb;6(1):38-69. doi: 10.1016/j.jaip.2017.11.023. J Allergy Clin Immunol Pract. 2018. PMID: 29310768 Free PMC article. Review.
Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, Iijima M, Morita E, Niihara H, Asada H, Kabashima K, Azukizawa H, Hashizume H, Nagao K, Takahashi H, Abe R, Sotozono C, Kurosawa M, Aoyama Y, Chu CY, Chung WH, Shiohara T. Kano Y, et al. Among authors: abe r. J Dermatol. 2015 Mar;42(3):276-82. doi: 10.1111/1346-8138.12770. Epub 2015 Jan 27. J Dermatol. 2015. PMID: 25623158
Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Aihara M, Kano Y, Fujita H, Kambara T, Matsukura S, Katayama I, Azukizawa H, Miyachi Y, Endo Y, Asada H, Miyagawa F, Morita E, Kaneko S, Abe R, Ochiai T, Sueki H, Watanabe H, Nagao K, Aoyama Y, Sayama K, Hashimoto K, Shiohara T; SJS/TEN Study Group. Aihara M, et al. Among authors: abe r. J Dermatol. 2015 Aug;42(8):768-77. doi: 10.1111/1346-8138.12925. Epub 2015 May 18. J Dermatol. 2015. PMID: 25982480 Clinical Trial.
New Advances in Drug Hypersensitivity Research and Treatment.
Tsai YG, Chung WH, Abe R, Tassaneeyakul W. Tsai YG, et al. Among authors: abe r. J Immunol Res. 2018 Jun 21;2018:9345078. doi: 10.1155/2018/9345078. eCollection 2018. J Immunol Res. 2018. PMID: 30035134 Free PMC article. No abstract available.
Galectin-7 as a potential biomarker of Stevens-Johnson syndrome/toxic epidermal necrolysis: identification by targeted proteomics using causative drug-exposed peripheral blood cells.
Hama N, Nishimura K, Hasegawa A, Yuki A, Kume H, Adachi J, Kinoshita M, Ogawa Y, Nakajima S, Nomura T, Watanabe H, Mizukawa Y, Tomonaga T, Shimizu H, Abe R. Hama N, et al. Among authors: abe r. J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2894-2897.e7. doi: 10.1016/j.jaip.2019.05.002. Epub 2019 May 14. J Allergy Clin Immunol Pract. 2019. PMID: 31100551 No abstract available.
1,467 results